Anika Therapeutics reported $290.06M in Equity Capital and Reserves for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Acceleron Pharma XLRN:US $ 718.15M 44.88M
Acorda Therapeutics ACOR:US $ 164.48M 26.01M
Adamas Pharmaceuticals ADMS:US -21606000 17.57M
Agios Pharmaceuticals AGIO:US $ 1394.76M 327.05M
Anika Therapeutics ANIK:US $ 290.06M 3.26M
Arrowhead Research ARWR:US $ 408.82M 28.07M
Chemocentryx CCXI:US $ 315.89M 14.38M
Clovis Oncology CLVS:US $ -225.46M 18.48M
Dicerna Pharmaceuticals DRNA:US $ 107.66M 3.41M
Enanta Pharmaceuticals ENTA:US $ 399.43M 18.42M
Flexion Therapeutics FLXN:US $ -82377000 26.21M
Halozyme Therapeutics HALO:US $ 281.67M 161.93M
Heron Therapeutics HRTX:US $ 118.84M 41.27M
Immunogen IMGN:US $ 77.09M 8.63M
Insmed INSM:US $ 504.84M 26.21M
Integra Lifesciences IART:US $ 1631.69M 56.71M
Intrexon XON:US $ 131.25M 27.95M
Karyopharm Therapeutics KPTI:US $ -125977000 42.84M
Ligand Pharmaceuticals LGND:US $ 812.07M 25.55M
Macrogenics MGNX:US $ 291.44M 27.61M
Merit Medical Systems MMSI:US $ 1013.38M 20.94M
Peregrine Pharmaceuticals PPHM:US $ 51.1M 6.47M
Rigel Pharmaceuticals RIGL:US $ 49.67M 18.44M
Sangamo Biosciences SGMO:US $ 406.02M 39.44M
Stryker SYK:US $ 14178M 358M
Surmodics SRDX:US $ 140.08M 0.75M
Veracyte VCYT:US $ 1107.08M 135.9M
Xencor XNCR:US $ 618.86M 28.08M
Zimmer Biomet Holdings Inc ZBH:US $ 12.71B 130.7M